These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 12383535)

  • 1. Effect of oral misoprostol after second-trimester delivery: a randomized, blinded study.
    Leader J; Bujnovsky M; Carlan SJ; Triana T; Richichi K
    Obstet Gynecol; 2002 Oct; 100(4):689-94. PubMed ID: 12383535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of oral misoprostol with vaginal misoprostol administration in second-trimester pregnancy termination for fetal abnormality.
    Dickinson JE; Evans SF
    Obstet Gynecol; 2003 Jun; 101(6):1294-9. PubMed ID: 12798539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of intramuscular 15-methyl prostaglandin F2 alpha after second-trimester delivery.
    Carlan SJ; Gushwa JP; O'Brien WF; Vu T
    Obstet Gynecol; 1997 Jan; 89(1):5-9. PubMed ID: 8990427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized controlled trial of misoprostol for second-trimester pregnancy termination associated with fetal malformation.
    Akoury HA; Hannah ME; Chitayat D; Thomas M; Winsor E; Ferris LE; Einarson TR; Seaward PG; Ryan G; Willan AR; Windrim R
    Am J Obstet Gynecol; 2004 Mar; 190(3):755-62. PubMed ID: 15042010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind randomized controlled trial of mifepristone or placebo before buccal misoprostol for abortion at 14-21 weeks of pregnancy.
    Dabash R; Chelli H; Hajri S; Shochet T; Raghavan S; Winikoff B
    Int J Gynaecol Obstet; 2015 Jul; 130(1):40-4. PubMed ID: 25896965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaginal misoprostol versus concentrated oxytocin and vaginal PGE2 for second-trimester labor induction.
    Ramsey PS; Savage K; Lincoln T; Owen J
    Obstet Gynecol; 2004 Jul; 104(1):138-45. PubMed ID: 15229013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of oral versus vaginal misoprostol on cervical dilatation in first-trimester abortion: a double-blind, randomized study.
    Inal MM; Ertopçu K; Arici A; Ozelmas I
    Eur J Contracept Reprod Health Care; 2003 Dec; 8(4):197-202. PubMed ID: 15006266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficacy and safety of mifepristone combined with misoprostol for termination of pregnancy between 8 and 16 weeks of gestation].
    Qian J; Jing X; Wu S; Zheng S; Li Y; Ren M; Di W; Shen H; Dong B; Chang Q; Shi H; Yao C; Song W; Huang Z
    Zhonghua Fu Chan Ke Za Zhi; 2015 Jul; 50(7):505-9. PubMed ID: 26311640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose vaginal misoprostol versus concentrated oxytocin plus low-dose vaginal misoprostol for midtrimester labor induction: a randomized trial.
    Nuthalapaty FS; Ramsey PS; Biggio JR; Owen J
    Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):1065-70. PubMed ID: 16157113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective double-blinded, randomized, placebo-controlled trial on the use of letrozole pretreatment with misoprostol for second-trimester medical abortion.
    Lee VC; Tang OS; Ng EH; Yeung WS; Ho PC
    Contraception; 2011 Dec; 84(6):628-33. PubMed ID: 22078193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Letrozole pretreatment prior to medical termination of pregnancy: a systematic review.
    Nash CM; Philp L; Shah P; Murphy KE
    Contraception; 2018 Jun; 97(6):504-509. PubMed ID: 29154779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of the third stage of labor in pregnancies terminated by prostaglandin E2.
    Kirz DS; Haag MK
    Am J Obstet Gynecol; 1989 Feb; 160(2):412-4. PubMed ID: 2916627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of two dosing regimens of intravaginal misoprostol for second-trimester pregnancy termination.
    Jain JK; Kuo J; Mishell DR
    Obstet Gynecol; 1999 Apr; 93(4):571-5. PubMed ID: 10214835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized comparison of vaginal (200 microg every 3 h) and oral (400 microg every 3 h) misoprostol when combined with mifepristone in termination of second trimester pregnancy.
    Ngai SW; Tang OS; Ho PC
    Hum Reprod; 2000 Oct; 15(10):2205-8. PubMed ID: 11006200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rectal misoprostol vs 15-methyl prostaglandin F2alpha for retained placenta after second-trimester delivery.
    Sundaram S; Diaz JP; González-Quintero VH; Verma U
    Am J Obstet Gynecol; 2009 May; 200(5):e24-6. PubMed ID: 19136084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaginal misoprostol compared with oral misoprostol in termination of second-trimester pregnancy.
    Ho PC; Ngai SW; Liu KL; Wong GC; Lee SW
    Obstet Gynecol; 1997 Nov; 90(5):735-8. PubMed ID: 9351755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized controlled trial comparing two protocols for the use of misoprostol in midtrimester pregnancy termination.
    Bebbington MW; Kent N; Lim K; Gagnon A; Delisle MF; Tessier F; Wilson RD
    Am J Obstet Gynecol; 2002 Oct; 187(4):853-7. PubMed ID: 12388963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The optimization of intravaginal misoprostol dosing schedules in second-trimester pregnancy termination.
    Dickinson JE; Evans SF
    Am J Obstet Gynecol; 2002 Mar; 186(3):470-4. PubMed ID: 11904609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Results of pregnancy termination for foetal congenital or chromosomal disorders or intrauterine foetal death by oral mifepristone and/or intravaginal misoprostol; results of a retrospective study].
    Verhulsdonk MT; Papatsonis DN; Heydanus R
    Ned Tijdschr Geneeskd; 2007 Apr; 151(14):815-20. PubMed ID: 17469323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Misoprostol for termination of pregnancy with intrauterine fetal demise in the second and third trimester of pregnancy - a systematic review.
    Gómez Ponce de León R; Wing DA
    Contraception; 2009 Apr; 79(4):259-71. PubMed ID: 19272495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.